Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Total Current Liabilities (2020 - 2025)

MDxHealth (MDXH) has disclosed Total Current Liabilities for 6 consecutive years, with $49.5 million as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities rose 16.11% to $49.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $49.5 million through Dec 2025, up 16.11% year-over-year, with the annual reading at $49.5 million for FY2025, 16.11% up from the prior year.
  • Total Current Liabilities hit $49.5 million in Q4 2025 for MDxHealth, up from $42.7 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $49.5 million in Q4 2025 to a low of $16.4 million in Q4 2021.
  • Historically, Total Current Liabilities has averaged $29.3 million across 5 years, with a median of $19.5 million in 2023.
  • Biggest five-year swings in Total Current Liabilities: grew 6.81% in 2023 and later skyrocketed 118.53% in 2024.
  • Year by year, Total Current Liabilities stood at $16.4 million in 2021, then grew by 11.23% to $18.3 million in 2022, then grew by 6.81% to $19.5 million in 2023, then skyrocketed by 118.53% to $42.7 million in 2024, then grew by 16.11% to $49.5 million in 2025.
  • Business Quant data shows Total Current Liabilities for MDXH at $49.5 million in Q4 2025, $42.7 million in Q4 2024, and $19.5 million in Q4 2023.